Specifically, OTR showed a trend towards higher relative expression in primary/metastasised gastroenteropancreatic neuroendocrine tumours versus normal tissue compared to the somatostatin receptor type 2 (SSTR2) [ 110 ], which is currently a known clinical ideal and successful receptor target for imaging and treatment displaying higher expression in tumour tissues with relatively low expression in the adjacent normal tissue.
← all excerpts
Oxytocin/Oxytocin Receptor Signalling in the Gastrointestinal System: Mechanisms and Therapeutic Potential.
1
—
—